Huan Meng

Active 2005–2026

162
Papers
23,092
Citations
71
h-index
122
i10-index

Citations

Citations per year for Huan Meng1987: 1 citations2002: 1 citations2005: 1 citations2006: 4 citations2007: 18 citations2008: 31 citations2009: 39 citations2010: 59 citations2011: 168 citations2012: 239 citations2013: 265 citations2014: 231 citations2015: 297 citations2016: 275 citations2017: 268 citations2018: 265 citations2019: 638 citations2020: 818 citations2021: 850 citations2022: 755 citations2023: 627 citations2024: 873 citations2025: 530 citations2026: 14 citations1988–2001: no citations, so these years are not shown2003–2004: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,853 citing papers, 31.6% of this breakdownUnited States: 1,589 citing papers, 17.6% of this breakdownIndia: 384 citing papers, 4.2% of this breakdownUnited Kingdom: 286 citing papers, 3.2% of this breakdownGermany: 272 citing papers, 3% of this breakdownItaly: 259 citing papers, 2.9% of this breakdownSouth Korea: 233 citing papers, 2.6% of this breakdownSpain: 225 citing papers, 2.5% of this breakdownAustralia: 216 citing papers, 2.4% of this breakdownIran: 155 citing papers, 1.7% of this breakdownFrance: 153 citing papers, 1.7% of this breakdownCanada: 142 citing papers, 1.6% of this breakdown
0%31.6%Other 25%

Fields

  • Materials Science24.8%
  • Biochemistry, Genetics and Molecular Biology22%
  • Medicine17.2%
  • Engineering15.3%
  • Immunology and Microbiology5.6%
  • Environmental Science2.2%
  • Other12.9%

Topics

  • Nanoparticle-Based Drug Delivery7.8%
  • Nanoplatforms for cancer theranostics7.8%
  • RNA Interference and Gene Delivery5%
  • Nanoparticles: synthesis and applications4.3%
  • Advanced biosensing and bioanalysis techniques4%
  • Immunotherapy and Immune Responses2.3%
  • Other68.8%

Coauthors

All papers

Open in search
  1. Design of Diselenide-Bridged Hyaluronic Acid Nano-antioxidant for Efficient ROS Scavenging to Relieve Colitis

    Authors: , , , , , , , , - ACS Nano 2022 cited by 256

  2. Diverse Applications of Nanomedicine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark C. Hersam, Patrick Hunziker, Jian Ji, Xingyu Jiang, Philipp Jungebluth, Pranav Kadhiresan, Kazunori Kataoka, Ali Khademhosseini, Jindŕich Kopec̆ek, Nicholas A. Kotov, Harald F. Krug, Dong Soo Lee, Claus‐Michael Lehr, Kam W. Leong, Xing‐Jie Liang, Mei Ling Lim, Luis M. Liz‐Marzán, Xiaowei Ma, Paolo Macchiarini, Huan Meng, Helmuth Möhwald, Paul Mulvaney, André E. Nel, Shuming Nie, Peter Nordlander, Teruo Okano, J.P.R. de Oliveira, Tai Hyun Park, Reginald M. Penner, Maurizio Prato, Víctor Puntes, Vincent M. Rotello, Amila Samarakoon, Raymond E. Schaak, Youqing Shen, Sebastian Sjöqvist, André G. Skirtach, Mahmoud G. Soliman, Molly M. Stevens, Hsing‐Wen Sung, Ben Zhong Tang, Rainer Tietze, Buddhisha Udugama, J. Scott VanEpps, Tanja Weil, Paul S. Weiss, Itamar Willner, Yuzhou Wu, Lily Yang, Zhao Yue, Qian Zhang, Qiang Zhang, Xian‐En Zhang, Yuliang Zhao, Xin Zhou, Wolfgang J. Parak - ACS Nano 2017 cited by 1,341

  3. Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression

    Authors: , , , , , , , , , , , - Nature Communications 2017 cited by 439

  4. Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jin Wang, Qizhi Yao, Bing Zhang, Jack A. Roth, Bert W. O’Malley, Matthew J. Ellis, Mothaffar F. Rimawi, Haoqiang Ying, Xi Chen - Science 2023 cited by 110

  5. Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer

    Authors: , , , , , , , , , , - Nanoscale 2019 cited by 228

  6. Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy in Multiple Solid Tumors

    Authors: , , , , , , , , , , , , , , , , - ACS Nano 2020 cited by 167

  7. DNA Methylation, Its Mediators and Genome Integrity

    Authors: , , , , , , - International Journal of Biological Sciences 2015 cited by 326

  8. Synergistic Chemoimmunotherapy Augmentation via Sequential Nanocomposite Hydrogel‐Mediated Reprogramming of Cancer‐Associated Fibroblasts in Osteosarcoma

    Authors: , , , , , , , , , - Advanced Materials 2023 cited by 67

  9. Physicochemical Properties Determine Nanomaterial Cellular Uptake, Transport, and Fate

    Authors: , , , , , - Accounts of Chemical Research 2012 cited by 799

  10. The role and mechanism of flavonoid herbal natural products in ulcerative colitis

    Authors: , , , , , , , , - Biomedicine & Pharmacotherapy 2022 cited by 121

  11. Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer

    Authors: , , , , , , , , - ACS Nano 2016 cited by 263

  12. Combination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1

    Authors: , , , , , , , , , , , , , , - Advanced Science 2021 cited by 132

  13. Engineered Design of a Mesoporous Silica Nanoparticle-Based Nanocarrier for Efficient mRNA Delivery in Vivo

    Authors: , , , , , , , , , , , , - Nano Letters 2023 cited by 71

  14. New Insights into “Permeability” as in the Enhanced Permeability and Retention Effect of Cancer Nanotherapeutics

    Authors: , , - ACS Nano 2017 cited by 300

  15. Use of Polymeric Nanoparticle Platform Targeting the Liver To Induce Treg-Mediated Antigen-Specific Immune Tolerance in a Pulmonary Allergen Sensitization Model

    Authors: , , , , , , , , , , , , , , - ACS Nano 2019 cited by 122

  16. Engineered Design of Mesoporous Silica Nanoparticles to Deliver Doxorubicin and P-Glycoprotein siRNA to Overcome Drug Resistance in a Cancer Cell Line

    Authors: , , , , , , - ACS Nano 2010 cited by 895

  17. The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis

    Authors: , , , , , , , , , , , - Frontiers in Oncology 2022 cited by 64

  18. Use of Metal Oxide Nanoparticle Band Gap To Develop a Predictive Paradigm for Oxidative Stress and Acute Pulmonary Inflammation

    Authors: , , , , , , , , , , , , , , , , , , - ACS Nano 2012 cited by 817

  19. Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice

    Authors: , , , , , , , , - ACS Nano 2015 cited by 436

  20. Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo

    Authors: , , , , , , , , , , - ACS Nano 2013 cited by 571

  21. Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer

    Authors: , , , , , , , , , , , - Journal of Clinical Investigation 2017 cited by 222

  22. Traditional Chinese Medicine and Natural Products: Potential Approaches for Inflammatory Bowel Disease

    Authors: , , , , , , , , - Frontiers in Pharmacology 2022 cited by 45

  23. Polyethyleneimine Coating Enhances the Cellular Uptake of Mesoporous Silica Nanoparticles and Allows Safe Delivery of siRNA and DNA Constructs

    Authors: , , , , , , , - ACS Nano 2009 cited by 908

  24. Organothianthrenium salts: synthesis and utilization

    Authors: , , - Chemical Science 2022 cited by 247